Diagonal Earlobe Crease (Frank's Sign) and Cardiovascular Risk
A diagonal earlobe crease (Frank's sign) is a marker of increased cardiovascular risk that should prompt comprehensive cardiovascular risk assessment using validated tools (Framingham, PREVENT, or Pooled Cohort Equations) and aggressive management of modifiable risk factors, particularly in patients with bilateral, deep creases.
What Frank's Sign Indicates
Frank's sign represents an independent cardiovascular risk marker associated with:
- Coronary artery disease: Bilateral DELC shows independent association with obstructive CAD (OR 1.36,95% CI 1.07-1.74) 1
- Cerebrovascular events: Present in 78.8% of acute stroke patients, with significantly higher prevalence in cerebrovascular accidents (88.6%) versus transient ischemic attacks (73.2%, P <0.01) 2
- Elevated cardiovascular risk scores: Individuals with bilateral creases have 58% prevalence of moderate-to-very-high cardiovascular risk versus 23.8% without creases (P <0.001) 3
The crease severity matters—longest, deepest, bilateral creases with accessory creases correlate with highest cardiovascular risk 3.
Key Risk Factors Associated with Frank's Sign
The strongest independent associations are 4:
- Age >55 years (OR 4.8,95% CI 3.2-7.2)
- Male sex (OR 1.6-2.04)
- Obesity (OR 2.1,95% CI 1.4-3.1)
- Arterial hypertension (OR 1.5,95% CI 1.1-2.3)
- Acute coronary syndrome (OR 5.3,95% CI 2.5-11.1)
Recommended Evaluation Algorithm
1. Immediate Risk Stratification
Calculate 10-year cardiovascular risk using 5:
- Framingham Risk Score or
- Pooled Cohort Equations or
- PREVENT equations (most recent)
Target threshold: ≥7.5% 10-year risk warrants intensive intervention 6.
2. Traditional Risk Factor Assessment 7
Measure at baseline:
- Blood pressure (target <140/85 mmHg, <130/80 mmHg if diabetic) 8
- Fasting lipid panel (target total cholesterol <5.0 mmol/L, LDL <3.0 mmol/L) 8
- Fasting glucose/HbA1c
- Body mass index and waist circumference
- Smoking status
3. Consider Risk-Enhancing Factors 9
Particularly relevant with Frank's sign:
- Family history of premature ASCVD (males <55y, females <65y)
- Chronic kidney disease (eGFR 15-59 mL/min/1.73 m²)
- Metabolic syndrome
- Chronic inflammatory conditions
4. Additional Testing for Intermediate Risk (5-7.5%) 5
When risk calculation is borderline:
- 12-lead ECG (Class I recommendation) to screen for left ventricular hypertrophy 6
- Consider coronary artery calcium (CAC) scoring if ≥40 years with diabetes 10
- High-sensitivity C-reactive protein (>2.0 mg/L indicates increased risk) 5
Preventive Interventions
For ALL Patients with Frank's Sign 8, 9:
Lifestyle modifications:
- Smoking cessation (mandatory)
- Mediterranean or DASH diet
- ≥150 minutes/week moderate-intensity aerobic exercise
- Weight loss if BMI ≥25 kg/m²
- Alcohol moderation
Pharmacologic Therapy Based on Risk 11, 8:
High risk (≥15% 10-year risk) or established CVD:
- Aspirin 75-100mg daily (unless contraindicated)
- Statin at doses from clinical trials (high-intensity if very high risk)
- ACE inhibitor (particularly if hypertensive, diabetic, or post-MI)
- Beta-blocker if prior MI
Intermediate risk (7.5-15%):
- Statin therapy if LDL ≥70 mg/dL after lifestyle modification
- Antihypertensive therapy if BP ≥140/90 mmHg (≥130/80 if diabetic) after 3-6 month lifestyle trial 6
- Consider aspirin if bleeding risk is low
- General population: <140/85 mmHg
- Diabetes: <130/80 mmHg (<125/75 if proteinuria)
- Consider intensive BP lowering (systolic <120 mmHg) in very high-risk patients
Critical Caveats
Frank's sign has modest diagnostic accuracy as a stand-alone marker 1—it reflects underlying cardiovascular risk burden rather than serving as an independent diagnostic tool 12. The sign's presence increases with age and may simply represent aging-related connective tissue changes 4.
Do not use Frank's sign alone to make treatment decisions. Always integrate it with validated risk calculators and traditional risk factors 5. The sign is most useful for identifying patients who warrant comprehensive cardiovascular evaluation 13, not as a screening tool for the general population.
Bilateral, deep creases warrant more aggressive risk factor assessment and management than unilateral or superficial creases 3.